Balstilimab + evofosfamide + zalifrelimab
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Balstilimab + evofosfamide + zalifrelimab for prostatic neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Balstilimab + evofosfamide + zalifrelimab for squamous cell carcinoma of head and neck | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |